Methotrexate use in a breastfeeding patient with rheumatoid arthritis.

J Rheumatol

Division Head, Clinical Pharmacology and Toxicology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140263DOI Listing

Publication Analysis

Top Keywords

methotrexate breastfeeding
4
breastfeeding patient
4
patient rheumatoid
4
rheumatoid arthritis
4
methotrexate
1
patient
1
rheumatoid
1
arthritis
1

Similar Publications

Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review.

J Crohns Colitis

October 2024

Department of Gastroenterology, Inflammatory Bowel Disease Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-Princesa], Universidad Autónoma de Madrid [UAM], Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBEREHD], Madrid, Spain.

Inflammatory bowel disease [IBD] is often diagnosed in patients during their reproductive years. It is crucial that both healthcare providers and patients are adequately informed to avoid misguided decisions regarding family planning. One of the most important aspects during conception and pregnancy is to maintain disease remission, as disease activity is associated with adverse pregnancy outcomes.

View Article and Find Full Text PDF

Background: Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory breast condition often mistaken for inflammatory breast cancer and, therefore, requires a biopsy for accurate diagnosis. Although not cancerous, IGM can cause emotional distress because of severe pain and ensuing breast deformity. Differentiating IGM from other breast inflammations caused by infections is essential.

View Article and Find Full Text PDF

Comparing the effectiveness of letrozole versus methotrexate for treatment of ectopic pregnancy: A randomized controlled trial.

Eur J Obstet Gynecol Reprod Biol

August 2024

Female Pelvic Medicine and Reconstructive Surgery (FPMRS) Division, University of Chicago Pritzker School of Medicine, Northshore University HealthSystem, Skokie, IL, USA.

Article Synopsis
  • - This study aimed to compare the effectiveness of two Letrozole regimens against methotrexate in treating ectopic pregnancy among 88 women with low beta-human chorionic gonadotropin levels.
  • - Participants were divided into three groups: methotrexate, 5-day Letrozole, and 10-day Letrozole, with treatment response assessed by achieving a negative serum beta level without further treatment or surgery.
  • - Results showed that the treatment response rates were similar across all groups (76.7% for methotrexate, 75.0% for 5-day Letrozole, and 90.5% for 10-day Letrozole), indicating no significant differences, and only a small
View Article and Find Full Text PDF

Background: Inflammatory bowel disease (IBD) affects young adults of reproductive age, and questions related to pregnancy and breastfeeding are common in clinical practice. Most medications used to treat IBD are considered safe during pregnancy, except methotrexate and small molecules such as tofacitinib. Despite few studies regarding vedolizumab (VDZ) safety, it appears to be safe during pregnancy.

View Article and Find Full Text PDF

Psoriasis is a common inflammatory skin condition with an estimated prevalence of 1.5% in the UK. Its management has evolved rapidly over the past 15 years as our understanding of its pathogenesis has progressed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!